Driving clinical excellence through strategic partnerships - the Greater Bay Area (GBA) International Oncology Symposium 2024 co-hosted by Gleneagles Hospital Hong Kong ignites dialogue to enahnce cancer care and research.
From 23- 24 March, Gleneagles Hospital Hong Kong co-hosted the Greater Bay Area (GBA) International Oncology Symposium 2024, in partnership with The University of Hong Kong-Shenzhen Hospital and Hong Kong University’s Li Ka Shing Faculty of Medicine.
Renowned global cancer experts gathered to explore latest developments in various cancer types, precision cancer medicine, and ways to enhance the quality and effectiveness of cancer care, as well as opportunities for clinical service and research collaboration in the Greater Bay Area.
Dr Kenneth Tsang, CEO of Gleneagles Hospital Hong Kong, highlighted the hospital’s commitment to oncology care, stating, “Through our close collaboration with HKU and oncology experts, we have established several oncology centres and implemented Tumor Boards, where cases are regularly reviewed to ensure the most effective patient care plans. They also serve as platforms for exploring the latest technologies in cancer diagnosis and treatments, fostering professional and academic exchange and development.”
With insights gained from these discussions, Gleneagles Hospital Hong Kong remains at the forefront of oncology care, offering hope and improved outcomes to cancer patients across the Greater Bay Area and beyond.
Related Stories
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme
Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.
IHH Healthcare Wins Four Awards for Leadership and Learning Excellence
IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.
